COVID-19
Research conducted by Aga Khan University in Karachi, Pakistan, has highlighted the substantial impact of respiratory tract infections (RTIs) on global health, particularly in low- and middle-income countries. The study, which evaluated the burden of RTIs in mortality cases during the post-COVID-19 pandemic period, found that RTIs significantly contribute to
COVID-19
Fresh data from a retrospective cohort study published in the Journal of Assisted Reproduction and Genetics have shed light on the impact of SARS-CoV-2 infection during controlled ovarian stimulation (COS) on pregnancy and obstetric outcomes in frozen-thawed embryo transfer (FET) cycles. The study, conducted by researchers from the First Affiliated
Vaccines
Researchers at Sichuan University have successfully produced SARS-CoV-2 virus-like particles (VLPs) as a vaccine candidate using a novel method that addresses the challenges of large-scale production. This breakthrough has the potential to provide a high-immunogenicity and low-cost vaccine platform for COVID-19. The study demonstrates the production of VLPs using HEK293T
COVID-19
Researchers from Kaiser Permanente Northern California have found that COVID-19 vaccine boosters provide significant protection against severe COVID-19 in people with cancer, despite low uptake of these vaccines in this high-risk population. The study's findings suggest that COVID-19 booster vaccinations are associated with a reduced risk of COVID-19
Vaccines
Research conducted among parents in Shenzhen, China, found that approximately 43.6% of parents reported vaccine hesitancy for their in-school children after the end of the zero-COVID-19 policy in South China. The study identified parents with anxiety, depression, and high-stress levels as more likely to report vaccine hesitancy. The research
COVID-19
Research findings have shown that in Italy, epilepsy surgery volumes have regained their pre-pandemic levels, albeit with a slight loss of complexity, whereas seizure outcome has remained stable. The study, conducted by Federico Vigevano and colleagues from the Institute for Cancer Research and Treatment (IRCCS), aimed to investigate the current
Vaccines
As children go back to school, coronavirus infections are on the rise, marking another summer wave. However, this uptick is accompanied by an added layer of uncertainty due to the unclear timeline for receiving updated vaccines in the fall. Medical experts are worried that delays and confusion surrounding the vaccines
COVID-19
Research on the effects of non-pharmaceutical interventions (NPIs) on respiratory infections in children has yielded new insights. A recent study conducted at the Third Affiliated Hospital of Zhengzhou University in the People's Republic of China found that NPIs had a significant impact on the prevalence and seasonal distribution
COVID-19
Beijing researchers have developed a novel virus-like particle system to study the life cycle of SARS-CoV-2, providing a safer and more accessible tool for scientists. This method, called SC2-VLP, effectively mimics the critical stages of the viral life cycle without the need for biosafety level 3 (BSL-3) laboratories. The system
Vaccines
COVID-19 vaccine hesitancy in China is a complex issue that has undergone significant changes over time. Recent research from Huaibei Normal University has shed light on the key factors influencing vaccine decision-making, revealing a shift from social norms to subjective experiences and from safety concerns to effectiveness priorities. The study
Vaccines
A new report has shed light on the potential for COVID-19 vaccines to trigger rare neurological complications, highlighting the need for ongoing research and surveillance to create safer vaccines and identify susceptible individuals. According to a recent study published in the AIMS Neuroscience journal, COVID-19 vaccines have been effective in
COVID-19
A recent study published in the Emerging Microbes & Infections journal has shed light on the concomitant administration of seasonal influenza and COVID-19 mRNA vaccines. The research, conducted by a team of scientists at the Icahn School of Medicine at Mount Sinai, aimed to understand the impact of mRNA COVID-19
